Transcriptional Changes Common to Human Cocaine, Cannabis and Phencyclidine Abuse

• Elin Lehrmann ,

  *To whom correspondence should be addressed. E-mail: elehrman@intra.nida.nih.gov

  Affiliations Cellular Neurobiology Research Branch, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America, Chemistry and Drug Metabolism Section, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America

  ⨯
• Carlo Colantuoni,

  Affiliation Clinical Brain Disorders Branch, GCAP, National Institute of Mental Health (NIMH) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Amy Deep-Soboslay,

  Affiliation Clinical Brain Disorders Branch, GCAP, National Institute of Mental Health (NIMH) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Kevin G. Becker,

  Affiliation Research Resources Branch, National Institute on Aging (NIA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America

  ⨯
• Ross Lowe,

  Affiliation Chemistry and Drug Metabolism Section, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America

  ⨯
• Marilyn A. Huestis,

  Affiliation Chemistry and Drug Metabolism Section, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America

  ⨯
• Thomas M. Hyde,

  Affiliation Clinical Brain Disorders Branch, GCAP, National Institute of Mental Health (NIMH) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• Joel E. Kleinman,

  Affiliation Clinical Brain Disorders Branch, GCAP, National Institute of Mental Health (NIMH) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America

  ⨯
• William J. Freed

  Affiliation Cellular Neurobiology Research Branch, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland, United States of America

  ⨯